A detailed history of Royal Bank Of Canada transactions in X Biotech Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 2,438 shares of XBIT stock, worth $16,237. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,438
Previous 1,948 25.15%
Holding current value
$16,237
Previous $10,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.55 - $7.95 $2,719 - $3,895
490 Added 25.15%
2,438 $18,000
Q2 2024

Aug 14, 2024

BUY
$4.54 - $9.89 $8,394 - $18,286
1,849 Added 1867.68%
1,948 $10,000
Q1 2024

Nov 05, 2024

SELL
$4.03 - $8.13 $7,451 - $15,032
-1,849 Reduced 94.92%
99 $0
Q1 2024

May 15, 2024

SELL
$4.03 - $8.13 $761 - $1,536
-189 Reduced 65.63%
99 $0
Q4 2023

Feb 14, 2024

SELL
$3.56 - $4.65 $4,083 - $5,333
-1,147 Reduced 79.93%
288 $1,000
Q3 2023

Nov 14, 2023

SELL
$4.02 - $5.81 $5,314 - $7,680
-1,322 Reduced 47.95%
1,435 $5,000
Q2 2023

Aug 14, 2023

BUY
$3.06 - $6.38 $930 - $1,939
304 Added 12.39%
2,757 $16,000
Q1 2023

May 15, 2023

BUY
$3.22 - $4.72 $1,458 - $2,138
453 Added 22.65%
2,453 $8,000
Q2 2022

Aug 15, 2022

SELL
$5.13 - $9.2 $4,801 - $8,611
-936 Reduced 31.88%
2,000 $11,000
Q1 2022

May 16, 2022

SELL
$8.64 - $11.71 $14,143 - $19,169
-1,637 Reduced 35.8%
2,936 $25,000
Q4 2021

Feb 14, 2022

BUY
$10.95 - $16.07 $14,213 - $20,858
1,298 Added 39.63%
4,573 $51,000
Q3 2021

Nov 15, 2021

BUY
$12.95 - $18.24 $3,172 - $4,468
245 Added 8.09%
3,275 $43,000
Q2 2021

Aug 16, 2021

BUY
$15.83 - $17.84 $47,964 - $54,055
3,030 New
3,030 $50,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $203M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.